CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
MorphoSys AG - ADR Company Snapshot
MorphoSys AG operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MorphoSys AG with three other companies in this sector in the United States: Radius Health Inc (2018 sales of $99.24 million of which 100% was Drug Manufacturer), Recro Pharma Inc ($77.35 million of which 100% was CDMO), and SAGE Therapeutics Inc ($90.27 million of which 100% was Biopharmaceutic).

Sales Analysis. During the year ended December of 2018, sales at MorphoSys AG were $90.07 million. This is an increase of 18.4% versus 2017, when the company's sales were $76.08 million. Sales of Proprietary Development saw an increase that was more than double the company's growth rate: sales were up 214.4% in 2018, from $20.09 million to $63.17 million. Not all segments of MorphoSys AG experienced an increase in sales in 2018: sales of Partnered Discovery fell 52.0% to $26.90 million.
   
   
 
  Stock Performance Chart for MorphoSys AG - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 32.87
(Figures in U.S. Dollars)
1 Week 7.3%   13 Weeks 21.8%  
4 Weeks 11.7%   52 Weeks 19.0%  
 
MorphoSys AG - ADR Key Data:
  Ticker: MOR Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 90,069,146
(Year Ending Jan 2019).
Employees: 329
  Currency: U.S. Dollars Market Cap: 4,165,034,221
  Fiscal Yr Ends: December Shares Outstanding: 126,712,328
  Share Type: American Depository Recei Closely Held Shares: 9,822,144
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.